6750.13147). Electronic supplementary material Additional file 1: Figure S1: Formulation

and schematic diagram. Formulation and schematic diagram of irrad and non-irrad liposomes. (TIFF 842 KB) Additional file 2: Figure S2: Time-concentration curve. Time-concentration curve of free and liposomal ADR by PK software. (TIFF 45 KB) References 1. Shankland KR, Armitage JO, Hancock BW: Non-Hodgkin lymphoma. Lancet 2012, 380:848–857. 10.1016/S0140-6736(12)60605-9CrossRef 2. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 1991, 67:1075–1087. 10.1016/0092-8674(91)90285-7CrossRef CHIR-99021 ic50 3. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park

CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R: Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010, 142:699–713. 10.1016/j.cell.2010.07.044CrossRef 4. Moncada B, Sobrevilla-Ondarza S, Md JD: Radiotherapy supports a better outcome than chemotherapy in cutaneous natural killer (NK)/T cell CYT387 lymphoma nasal type. Int J Dermatol 2013, 52:1276–1277. 5. Reimer P, Chawla S: Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphoma. J Hematol Oncol 2013, 6:69. 10.1186/1756-8722-6-69CrossRef 6. Kim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko YH, Suh C, Kim

WS: Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood 2011, 117:1958–1965. 10.1182/blood-2010-06-288480CrossRef 7. Ganta S, Devalapally H, Shahiwala A, Amiji M: A review of stimuli-responsive MAPK inhibitor nanocarriers for drug and gene delivery. J Control Release 2008, 126:187–204. 10.1016/j.jconrel.2007.12.017CrossRef 8. Dickerson EB, Blackburn WH, Smith MH, Kapa LB, Lyon LA, McDonald JF: Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer 2010, 10:10. 10.1186/1471-2407-10-10CrossRef 9. Kang CM, Koo HJ, Lee S, Lee KC, Oh YK, Choe YS: 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET www.selleckchem.com/products/Imatinib-Mesylate.html imaging of tumor angiogenesis. Nucl Med Biol 2013, 40:1018–1024. 10.1016/j.nucmedbio.2013.08.003CrossRef 10.